BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT00179699-completion@plaintrial.com
DTSTAMP:20261030T203405Z
DTSTART;VALUE=DATE:200611
SUMMARY:Phase I Open-Label\, Dose Escalation Study To Determine The Maximum
  Tolerated Dose And To Evaluate The Safety Profile Of Lenalidomide (Revlim
 id®\, CC-5013) With Pemetrexed In Subjects With Advanced Non-Small Cell L
 ung Cancer — estimated completion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT00179699
URL:https://plaintrial.com/trial/NCT00179699
END:VEVENT
END:VCALENDAR